BioPorto Diagnostics Product overview 2012
March 02 2012 by BioPorto Diagnostics
June 23 2009 by Camilla Recke
Material Safety Data Sheet (MSDS) for AntibodyShop unconjugated antibodies MON*.
Material According to Annex II of EC Regulation No. 1907/2006 concerning REACH
Emerging biomarkers for Acute Kidney Injury
May 01 2009 by Dr. Prasad Devarajan
Early diagnosis of AKI currently depends on detection of reduced kidney function by the rise in serum creatinine concentration, an unreliable measure in the acute setting. This article discusses the pros and cons of emerging early biomarkers which may prove useful.
November 21 2008 by Dr. L. O. Uttenthal
Dr. Lars Otto Uttenthal, Scientific Director of BioPorto Diagnostics, presented the latest data on the new biomarker APC-PCI in Granada, Spain, last November 21, 2008.
Gut hormones and obesity: GLP-1 and co-secreted peptides
May 07 2008 by Dr. L. O. Uttenthal
The anorectic gut hormones GLP-1 (glucagon-like peptide 1) and co-secreted peptides such as oxyntomodulin and PYY are among prime candidates for manipulation in the development of new therapies for obesity. Here their secretion and actions in pathways regulating food intake are briefly outlined.